BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33312758)

  • 1. Intratumoral CD103
    Gu Y; Chen Y; Jin K; Cao Y; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Qin J; Li R; Zhang H; Zhang W
    Oncoimmunology; 2020 Nov; 9(1):1844402. PubMed ID: 33312758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor clinical outcomes of intratumoral dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin-positive macrophages associated with immune evasion in gastric cancer.
    Liu X; Cao Y; Li R; Gu Y; Chen Y; Qi Y; Lv K; Wang J; Yu K; Lin C; Liu H; Zhang H; He H; Chen L; Zhang P; Shen Z; Qin J; Sun Y; Li H; Huang H; Zhang W; Xu J
    Eur J Cancer; 2020 Mar; 128():27-37. PubMed ID: 32109848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral CXCL13
    Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral Foxp3
    Fei Y; Cao Y; Gu Y; Fang H; Chen Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Zhang W
    Cancer Immunol Immunother; 2022 Jan; 71(1):1-11. PubMed ID: 33978826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating podoplanin
    Liu X; Cao Y; Lv K; Gu Y; Jin K; He X; Fang H; Fei Y; Shi M; Lin C; Liu H; Li H; He H; Xu J; Li R; Zhang H
    Oncoimmunology; 2020 Nov; 9(1):1845038. PubMed ID: 33235820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients.
    Jin K; Cao Y; Gu Y; Fang H; Fei Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Xu J
    Oncoimmunology; 2021 Apr; 10(1):1915560. PubMed ID: 33996266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients.
    Zhang H; Li R; Cao Y; Gu Y; Lin C; Liu X; Lv K; He X; Fang H; Jin K; Fei Y; Chen Y; Wang J; Liu H; Li H; Zhang H; He H; Zhang W
    Ann Surg; 2022 Apr; 275(4):e626-e635. PubMed ID: 32541216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latency-associated Peptide Identifies Immunoevasive Subtype Gastric Cancer With Poor Prognosis and Inferior Chemotherapeutic Responsiveness.
    Cao Y; He H; Li R; Liu X; Chen Y; Qi Y; Yu K; Wang J; Lin C; Liu H; Zhang H; Li H; Chen L; Zhang P; Shen Z; Huang H; Sun Y; Zhang W; Qin J; Xu J
    Ann Surg; 2022 Jan; 275(1):e163-e173. PubMed ID: 32511132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103
    Li R; Liu H; Cao Y; Wang J; Chen Y; Qi Y; Lv K; Liu X; Yu K; Lin C; Zhang H; He H; Li H; Chen L; Shen Z; Qin J; Zhang W; Sun Y; Xu J
    Br J Cancer; 2020 May; 122(10):1525-1534. PubMed ID: 32205862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
    Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
    Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
    Zeng H; Liu Z; Wang Z; Zhou Q; Qi Y; Chen Y; Chen L; Zhang P; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
    Int J Cancer; 2020 Jan; 146(2):542-552. PubMed ID: 31584197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral TIGIT
    Liu Z; Zhou Q; Wang Z; Zhang H; Zeng H; Huang Q; Chen Y; Jiang W; Lin Z; Qu Y; Xiong Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Wang J; Chang Y; Zhang W
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32817209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Heterogeneity of CD4
    Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
    Front Immunol; 2018; 9():2654. PubMed ID: 30505306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte-activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein-Barr virus-positive and MLH1-defective gastric cancer patients.
    Lv K; Li R; Cao Y; Gu Y; Liu X; He X; Jin K; Fang H; Fei Y; Shi M; Liu H; Li H; He H; Lin C; Zhang H; Xu J
    Int J Cancer; 2021 Feb; 148(3):759-768. PubMed ID: 33105024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes and Immune Metrics in Intratumoral Basophil-Enriched Gastric Cancer Patients.
    He X; Cao Y; Gu Y; Fang H; Wang J; Liu X; Lv K; Yu K; Fei Y; Lin C; Liu H; Zhang H; Li H; Xu J; Li R; He H
    Ann Surg Oncol; 2021 Oct; 28(11):6439-6450. PubMed ID: 33738713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of tumour-infiltrating CD103
    Zhou Q; Ou Y; Dai X; Chen X; Wu S; Chen W; Hu M; Yang C; Zhang L; Jiang H
    Br J Cancer; 2023 Apr; 128(8):1466-1477. PubMed ID: 36759726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltration and Significance of CD103+CD8+ T Cells in Gastrointestinal Adenocarcinoma.
    Cai W; Wang H
    Biomed Res Int; 2022; 2022():7469041. PubMed ID: 36119930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral PD-1
    Yu K; Gu Y; Zhang P; Fang H; Cao Y; Wang J; Lin C; Liu H; Zhang H; He H; Li R; Qin J; Li H; Xu J
    Br J Cancer; 2022 Nov; 127(9):1709-1717. PubMed ID: 36002752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma.
    Workel HH; Komdeur FL; Wouters MC; Plat A; Klip HG; Eggink FA; Wisman GB; Arts HJ; Oonk MH; Mourits MJ; Yigit R; Versluis M; Duiker EW; Hollema H; de Bruyn M; Nijman HW
    Eur J Cancer; 2016 Jun; 60():1-11. PubMed ID: 27038842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8
    Li R; Zhang H; Cao Y; Liu X; Chen Y; Qi Y; Wang J; Yu K; Lin C; Liu H; He H; Li H; Chen L; Shen Z; Qin J; Zhang W; Sun Y; Xu J
    Cancer Immunol Immunother; 2020 Jul; 69(7):1327-1336. PubMed ID: 32200421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.